Evidence map›Paper›PMID 40897897›Full record

ArticleNature biomedical engineering2026

Fluid shear stress activates a targetable mechano-metastatic cascade to promote medulloblastoma metastasis.

Hyun-Kee Min, Hongyu Zhao, Alexander Bahcheli, Peng Pan, Jade Chan, Junsheng Chen, Esther Low, Yuxiao Zhou, Xian Wang, Savo Bajic and 13 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature biomedical engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. PIEZO2 in tumors: from mechanobiological switches to activity-targeted therapies.Journal of experimental & clinical cancer research : CR · 2025
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Hyun-Kee Min *Developmental, Stem Cell and Cancer Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada.
Hongyu Zhao *Developmental, Stem Cell and Cancer Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada.
Alexander BahcheliDepartment of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0001-6095-0233
Peng PanDepartment of Mechanical and Industrial Engineering, University of Toronto, Toronto, Ontario, Canada.
Jade ChanDevelopmental, Stem Cell and Cancer Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada.
Junsheng ChenDevelopmental, Stem Cell and Cancer Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada.
Esther LowDevelopmental, Stem Cell and Cancer Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada.
Yuxiao ZhouDepartment of Mechanical and Industrial Engineering, University of Toronto, Toronto, Ontario, Canada.
Xian WangDevelopmental, Stem Cell and Cancer Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada.
Savo BajicDepartment of Mechanical and Industrial Engineering, University of Toronto, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0002-9608-7133
Ran PengCollege of Marine Engineering, Dalian Maritime University, Dalian, China.
Siyi WanggouDevelopmental, Stem Cell and Cancer Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada.
Qi YangDevelopmental, Stem Cell and Cancer Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0001-8164-2141
Robert Du Yang ZhangDevelopmental, Stem Cell and Cancer Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada.
Leiming WangDepartment of Pathology, Xuanwu Hospital, Capital Medical University, Beijing, China.
Xiufang RenDepartment of Pathology, Shengjing Hospital, China Medical University, Shenyang, China.
Haoyue QiYu-Yue Pathology Scientific Research Center and Jinfeng Laboratory, Chongqing, China.
Yu ShiYu-Yue Pathology Scientific Research Center and Jinfeng Laboratory, Chongqing, China.ORCID http://orcid.org/0000-0002-3380-4545
Madeline N HayesDevelopmental, Stem Cell and Cancer Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada.
Brian CirunaDevelopmental, Stem Cell and Cancer Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0001-7918-0953
Jüri ReimandDepartment of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0002-2299-2309
Xinyu LiuDepartment of Mechanical and Industrial Engineering, University of Toronto, Toronto, Ontario, Canada.
Xi HuangDevelopmental, Stem Cell and Cancer Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada. xi.huang@sickkids.ca.ORCID http://orcid.org/0000-0002-7177-7525

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biofluid flow generates fluid shear stress (FSS), a mechanical force widely present in the tissue microenvironment. How brain tumour growth alters the conduit of biofluid and impacts FSS-regulated cancer progression is unknown. Dissemination of medulloblastoma (MB) cells into the cerebrospinal fluid initiates metastasis within the central nervous system. Here, by simulating cerebrospinal fluid dynamics based on magnetic resonance imaging of patients with MB, we discover that FSS is elevated at the cervicomedullary junction. MB-relevant FSS promotes metastasis along the mouse spinal cord. Mechanistically, FSS induces metastatic cell behaviours, including weakened cell-substrate adhesion, increased motility, cell clustering and plasma membrane localization of glucose transporter 1 (GLUT1) to enhance glucose uptake. FSS is perceived by the mechanosensitive ion channel PIEZO2, which drives actomyosin contractility-dependent GLUT1 recruitment at the plasma membrane. Genetic targeting of PIEZO2 or pharmacologic inhibition of GLUT1 mitigates metastasis. Collectively, these findings define a targetable FSS-activated mechano-metastatic cascade for the treatment of MB metastasis.

Indexed as

Cerebellar NeoplasmsMedulloblastomaStress, MechanicalAnimalsCell Line, TumorCell MembraneCell MovementGlucoseGlucose Transporter Type 1HumansIon ChannelsMagnetic Resonance ImagingMiceNeoplasm MetastasisGlucoseGlucose Transporter Type 1Ion ChannelsSLC2A1 protein, human

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.